HUP0105168A2 - Vérképző sejtek transzplantációja - Google Patents

Vérképző sejtek transzplantációja

Info

Publication number
HUP0105168A2
HUP0105168A2 HU0105168A HUP0105168A HUP0105168A2 HU P0105168 A2 HUP0105168 A2 HU P0105168A2 HU 0105168 A HU0105168 A HU 0105168A HU P0105168 A HUP0105168 A HU P0105168A HU P0105168 A2 HUP0105168 A2 HU P0105168A2
Authority
HU
Hungary
Prior art keywords
cells
transplantation
hematopoietic stem
haematopoietic cells
medicinal preparations
Prior art date
Application number
HU0105168A
Other languages
English (en)
Inventor
Jack Price
Original Assignee
Reneuron Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Limited filed Critical Reneuron Limited
Publication of HUP0105168A2 publication Critical patent/HUP0105168A2/hu
Publication of HUP0105168A3 publication Critical patent/HUP0105168A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány tárgya vérképző (hemopoetikus) őssejtek alkalmazásaszenzoros, motoros és/vagy kognitív elégtelenségek kezelésére szolgálógyógyszerkészítmények előállítására és intracerebrálistranszplantációra, továbbá maguk a sejtek, valamint ezeket a sejtekettartalmazó gyógyszerkészítmények. Hemopoetikus őssejtek sérült agybatörténő beültetése esetén a sejtek meglepő módon olyan sejtalakkádifferenciálódnak, amely képes helyreállítani a sérülést az agyban ésjavítani működését. Ó
HU0105168A 1999-02-24 2000-02-23 Transplantation of haematopoietic cells HUP0105168A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation

Publications (2)

Publication Number Publication Date
HUP0105168A2 true HUP0105168A2 (hu) 2002-05-29
HUP0105168A3 HUP0105168A3 (en) 2003-12-29

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105168A HUP0105168A3 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Country Status (20)

Country Link
EP (1) EP1161521B1 (hu)
JP (1) JP4716575B2 (hu)
KR (1) KR20020000216A (hu)
CN (1) CN1636053A (hu)
AT (1) ATE237680T1 (hu)
AU (1) AU762763B2 (hu)
CA (1) CA2361401A1 (hu)
CZ (1) CZ20012651A3 (hu)
DE (1) DE60002185T2 (hu)
DK (1) DK1161521T3 (hu)
ES (1) ES2193938T3 (hu)
GB (1) GB9904281D0 (hu)
HK (1) HK1041284B (hu)
HU (1) HUP0105168A3 (hu)
NO (1) NO20014091D0 (hu)
PL (1) PL350297A1 (hu)
PT (1) PT1161521E (hu)
RU (1) RU2216336C2 (hu)
SK (1) SK11232001A3 (hu)
WO (1) WO2000050568A2 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
AU780994B2 (en) * 1999-05-14 2005-04-28 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
EP1471918B1 (en) * 2002-01-14 2017-07-19 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
WO2004045666A1 (ja) * 2002-11-15 2004-06-03 Kyushu Tlo Company, Limited. 臓器の再生方法
ES2294650T3 (es) 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
CN101495623B (zh) 2006-03-24 2013-09-11 儿童医疗中心有限公司 调节造血干细胞生长的方法
MX2009004164A (es) 2006-10-20 2009-10-13 Childrens Medical Center Metodo para aumentar la regeneracion de tejido.
EP2326330B1 (en) 2008-09-16 2015-01-07 University Of Central Florida Research Foundation, Inc. Compositions for treating or delaying the onset of hair loss
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
CA2861440C (en) * 2011-04-20 2022-11-15 The Regents Of The University Of California Method for combined conditioning and chemoselection in a single cycle
EP2785350B1 (en) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Improved methods of treating ischemia
WO2013082243A1 (en) 2011-12-02 2013-06-06 Fate Therapeutics, Inc. Enhanced stem cell composition
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
KR950700403A (ko) * 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
CA2262817A1 (en) * 1996-08-19 1998-02-26 James Robl Embryonic or stem-like cell lines produced by cross species nuclear transplantation

Also Published As

Publication number Publication date
ES2193938T3 (es) 2003-11-16
WO2000050568A2 (en) 2000-08-31
HK1041284A1 (en) 2002-07-05
GB9904281D0 (en) 1999-04-21
AU762763B2 (en) 2003-07-03
DE60002185D1 (de) 2003-05-22
HUP0105168A3 (en) 2003-12-29
CA2361401A1 (en) 2000-08-31
CZ20012651A3 (cs) 2002-01-16
PL350297A1 (en) 2002-12-02
DK1161521T3 (da) 2003-06-16
JP2002537406A (ja) 2002-11-05
ATE237680T1 (de) 2003-05-15
JP4716575B2 (ja) 2011-07-06
HK1041284B (zh) 2003-10-03
PT1161521E (pt) 2003-08-29
KR20020000216A (ko) 2002-01-05
NO20014091L (no) 2001-08-23
NO20014091D0 (no) 2001-08-23
DE60002185T2 (de) 2003-12-18
EP1161521B1 (en) 2003-04-16
WO2000050568A3 (en) 2000-12-07
RU2216336C2 (ru) 2003-11-20
AU2682100A (en) 2000-09-14
CN1636053A (zh) 2005-07-06
SK11232001A3 (sk) 2002-01-07
EP1161521A2 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
HUP0105168A2 (hu) Vérképző sejtek transzplantációja
BR9910251A (pt) Estimulação hematopoiética
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
ATE229815T1 (de) In vitro methoden und verwendung von pharmazeutische zusammensetzungen für die behandlung von innenohrhaarzellen
TNSN97010A1 (fr) Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes.
ES2038350T5 (es) Procedimiento para la obtencion de pigmentos de brillo perlado especialmente con irisado azul.
HUP9802538A2 (hu) Vektorok és eljárások helyspecifikus rekombináció előidézésére
DE60216959D1 (de) Sich in schlagende kardiomyozyten verwandelnde stammzellen
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
NO166759C (no) Fremgangsmaate ved fjerning av hydrogensulfid samt vandig loesning for utfoerelse av fremgangsmaaten.
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
RU2001125914A (ru) Трансплантация гемопоэтических клеток
IL158385A0 (en) Modified cyclosporin which can be used as a pro-drug and use thereof
HUP0203197A2 (hu) Docetaxel alkalmazása hepatocelluláris karcinómák kezelésére
WO2005051978A3 (en) Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
EP0414019A3 (en) Subsituted n-(quinolin-2-yl-methoxy)benzylsulfonylureas
IT7926382A0 (it) Trattamento del gas di spurgo nella sintesi della ammoniaca.
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
ES2098316T3 (es) Procedimiento de purificacion de carrageninas comerciales.
DE69728536D1 (de) Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis
CH621224B (de) Mittel zur wachstumshemmung von mikroorganismen und algen.
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE50106928D1 (de) Verschlussträger und Einzelverschluss für Reaktionsgefässe sowie Vorrats- und Abgabeanordnung für Einzelverschlüsse
CA2519919A1 (en) Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
EP1252897A4 (en) MEDICINES FOR GENE THERAPY